- The study aimed to compare the effectiveness of multiple doses of vaginal clindamycin versus a single oral dose of secnidazole in treating bacterial vaginosis, using a double-blinded randomized controlled trial format.
- Conducted at Shifa Foundation Community Health Center between March 2012 and February 2015, participants were divided into two groups: one receiving clindamycin and the other receiving secnidazole, with treatment success measured after 15 days.
- Results showed that 96.6% of participants treated with vaginal clindamycin were cured of bacterial vaginosis, compared to only 23% in the secnidazole group, indicating that clindamycin is more effective for this condition.*